Table 4 Correlation of HFS-36 and SF-36 before/after BTX treatment
Subscales | PF | RP | RE | VT | MH | SF | BP | GH |
|---|---|---|---|---|---|---|---|---|
Mobility | -0.20/-0.25* | -0.36*/ 0.11 | -0.36*/-0.13 | -0.23*/-0.39* | -0.16/-0.33* | -0.22*/-0.23* | -0.17/-0.17 | -0.10/-0.09 |
ADL | -0.25*/-0.13 | -0.26*/-0.17 | -0.28*/-0.42* | -0.36*/-0.39* | -0.25*/-0.31* | -0.21*/-0.32* | -0.24*/-0.20 | -0.19/-0.26* |
Emotional well-being | -0.10/-0.17 | -0.11/-0.17 | -0.19/-0.07 | -0.31*/-0.29* | -0.42*/-0.41* | -0.33*/-0.28* | -0.12/-0.26* | -0.25*/-0.26* |
Stigma | -.013/0.04 | -0.08/-0.07 | -0.13/-0.27* | -0.26*/-0.18 | -0.38*/-0.36* | -0.41*/-0.30* | -0.03/-0.15 | -0.19/-0.15 |
Social support | 0.06/-0.15 | -0.26*/ 0.07 | -0.01/-0.28* | -0.05/-0.09 | -0.09/-0.13 | -0.11/-0.21 | 0.03/-0.14 | -0.04/-0.09 |
Cognition | -0.12/-0.12 | -0.19/-0.10 | -0.25*/-0.24* | -0.29/*-0.26* | -0.36*/-0.13 | -0.32*/-0.23* | -0.14/-0.10 | -0.23*/-0.12 |
Bodily discomfort | -0.32*/-0.31* | -0.22*/-0.14 | -0.23*/-0.29* | -0.34*/-0.22* | -0.22*/-0.18 | -0.12/-0.28* | -0.24*/-0.26* | -0.32*/-0.26* |
Communication | -0.17/-0.13 | -0.03/-0.04 | -0.15/-0.08 | 0.02/0.01 | 0.05/-0.14 | -0.11/-0.03 | 0.08/-0.11 | <0.01/-0.01 |